T. Rowe Price Investment Management
RPID icon

T. Rowe Price Investment Management’s Rapid Micro Biosystems RPID Stock Holding History

T. Rowe Price Investment Management’s Portfolio RPID Stock Details RPID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,194,185
Closed -$2.48M – 565
2022
Q4 		$2.48M Sell
2,194,185
-452,427
-17% -$1.1M ﹤0.01% 535
2022
Q3 		$8.55M Buy
+2,646,612
New +$10.3M 0.01% 510

Other funds holding RPID

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
KLM
Kennedy Lewis Management New York $21.9M AUM 12.46% 1-Year Est. Return
RMC
Resources Management Corp West Hartford, Connecticut $753M AUM 20.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management's RPID Position: Q1 2023 in Review

T. Rowe Price Investment Management sold out of Rapid Micro Biosystems (RPID) in Q1 2023, closing a stake of 2,194,185 shares — an estimated $2.48M sold.

T. Rowe Price Investment Management first reported a position in RPID in Q3 2022 and held it in 2 quarters. The position peaked at $8.55M in Q3 2022. 31 funds tracked by Wall St. Rank hold RPID as of Q1 2023.

  • T. Rowe Price Investment Management reported no remaining Rapid Micro Biosystems position as of Q1 2023 after selling out during the quarter.
  • T. Rowe Price Investment Management sold 2,194,185 Rapid Micro Biosystems shares in Q1 2023, an estimated $2.48M.
  • T. Rowe Price Investment Management first reported a position in Rapid Micro Biosystems in Q3 2022 and held it in 2 quarters.
  • T. Rowe Price Investment Management's Rapid Micro Biosystems position peaked at $8.55M in Q3 2022.
  • 31 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q1 2023.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2023, filed 15 May 2023.